Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain-Reference-Cited by-同舟云学术

Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain

Published:2019-10-09 Issue: Volume:9 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Szewczyk Katarzyna,Wieczorek Aleksandra,Młynarski Wojciech,Janczar Szymon,Woszczyk Mariola,Gamrot Zuzanna,Chaber Radosław,Wysocki Mariusz,Pogorzała Monika,Bik-Multanowski Mirosław,Balwierz Walentyna

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference21 articles.

1. International consensus for neuroblastoma molecular diagnostics: Report from the International Neuroblastoma Risk Group (INRG) Biology Committee;Ambros;Br J Cancer,2009

2. Poor survival for infants with MYCN amplified metastatic neuroblastoma despite intensified treatment: the International Society of Paediatric Oncology European Neuroblastoma Experience;Canete;J Clin Oncol,2009

3. Neuroblastoma and MYCN;Huang;Cold Spring Harb Perspect Med.,2013

4. The International Neuroblastoma Risk Group (INRG) classification system: an INRG task force report;Cohn;J Clin Oncol.,2009

5. Identification of patient subgroups with markedly disparate rates of MYCN amplification in neuroblastoma: a report from the International Neuroblastoma Risk Group project;Thompson;Cancer.,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYCN Gene Copy Number Status Detected by FISH Method and Its Correlation with Outcome and Clinicopathological Variables in Childhood Neuroblastoma;MIDDLE EAST J CANCER;2024

2. Negr1-Derived Peptides Trigger ALK Degradation and Halt Neuroblastoma Progression In Vitro and In Vivo;Pharmaceutics;2023-09-12

3. Neuroblastoma arises in early fetal development and its evolutionary duration predicts outcome;Nature Genetics;2023-03-27

4. Mitochondria-associated gene expression perturbation predicts clinical outcomes and shows potential for targeted therapy in neuroblastoma;Frontiers in Pediatrics;2023-03-21

5. Segmental chromosomal aberrations as the poor prognostic factor in children over 18 months with stage 3 neuroblastoma without MYCN amplification;Frontiers in Oncology;2023-02-14